MBP metabolic pharmaceuticals limited

glad i got the 82, page-5

  1. 4,770 Posts.
    fin review: worst in asx 300 last week Down over 15% last week to top the losers list as reported in this morning's Australian Financial Review. What a super loser and why should things change. No product, no market, no income, management changes, starting ventures in a new area. Would you have bought these knowing these things would happen?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.